BCR and neoplasm: It has been demonstrated that DLBCL shows the highest basal phosphorylation levels of the BCR complex compared to other B-cell malignancies [9], and that the ongoing antigenic engagement of self-antigens on the BCR is required for tumor survival in activated B-cell (ABC) subtype DLBCL [10].